Enter your email address
Submit
Write your message
Volume 17, Issue 3 (July 2023)
IJT 2023, 17(3): 53-59 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Alypoor S, Abdolmaleki A, Mamoudi F, Haghighat K, Soluki M. Evaluation of the Neuroprotective Effect of Eugenol on the Improvement of Sciatic Nerve Injury in Rats. IJT 2023; 17 (3) :53-59
URL: http://ijt.arakmu.ac.ir/article-1-1216-en.html
URL: http://ijt.arakmu.ac.ir/article-1-1216-en.html
1- Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran.
2- Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran.; Department of Engineering Sciences, Faculty of Advanced Technologies, University of Mohaghegh Ardabili, Ardabili, Iran.
3- Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran. ,f.mahmoudi@uma.ac.ir
2- Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran.; Department of Engineering Sciences, Faculty of Advanced Technologies, University of Mohaghegh Ardabili, Ardabili, Iran.
3- Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran. ,
Abstract: (1061 Views)
Background: Sciatica is a common human disorder associated with chronic pain. To speed up the recovery of damaged sciatic nerve, using plant derivatives, such as Eugenol can be effective due to its known neuroprotective properties. This study, investigated the effects of Eugenol on the regenerative process of experimentally induced sciatic nerve injury in rats.
Methods: Twenty eight male Wistar rats weighing 250-300 grams were divided into four groups of seven rats each. The control and sciatica model groups received normal saline only. The other two groups of sciatica model received Eugenol intraperitoneally at either 50 or 100 mg/kg daily for one week. Behavioral tests were also performed, and samples of the gastrocnemius muscles were removed under anesthesia for histopathological examinations.
Results: The pace of nerve injury improvement and recovery of both sensory and motor functions increased significantly in Eugenol-treated groups compared to both the sciatica model and control groups.
Conclusion: Eugenol administration improved the repair and regenerative process of the induced peripheral sciatic nerve damage in rats. Therefore, this compound may be considered as a beneficial treatment option for sciatica in humans.
Methods: Twenty eight male Wistar rats weighing 250-300 grams were divided into four groups of seven rats each. The control and sciatica model groups received normal saline only. The other two groups of sciatica model received Eugenol intraperitoneally at either 50 or 100 mg/kg daily for one week. Behavioral tests were also performed, and samples of the gastrocnemius muscles were removed under anesthesia for histopathological examinations.
Results: The pace of nerve injury improvement and recovery of both sensory and motor functions increased significantly in Eugenol-treated groups compared to both the sciatica model and control groups.
Conclusion: Eugenol administration improved the repair and regenerative process of the induced peripheral sciatic nerve damage in rats. Therefore, this compound may be considered as a beneficial treatment option for sciatica in humans.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
The Iranian Journal of Toxicology
Arak University of Medical Sciences in collaboration with the Iranian Society of Toxicology
Website: http://ijt.arakmu.ac.ir
Email: tox.journal@gmail.com
